BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Petrara MR, Freguja R, Gianesin K, Zanchetta M, De Rossi A. Epstein-Barr virus-driven lymphomagenesis in the context of human immunodeficiency virus type 1 infection. Front Microbiol. 2013;4:311. [PMID: 24151490 DOI: 10.3389/fmicb.2013.00311] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Nael A, Walavalkar V, Wu W, Nael K, Kim R, Rezk S, Zhao X. CD4-Positive T-Cell Primary Central Nervous System Lymphoma in an HIV Positive Patient. Am J Clin Pathol 2016;145:258-65. [PMID: 27124906 DOI: 10.1093/ajcp/aqv087] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
2 zur Hausen H, de Villiers EM. Cancer "causation" by infections--individual contributions and synergistic networks. Semin Oncol 2014;41:860-75. [PMID: 25499643 DOI: 10.1053/j.seminoncol.2014.10.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
3 Li C, Romero-Masters JC, Huebner S, Ohashi M, Hayes M, Bristol JA, Nelson SE, Eichelberg MR, Van Sciver N, Ranheim EA, Scott RS, Johannsen EC, Kenney SC. EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice. PLoS Pathog 2020;16:e1008590. [PMID: 32542010 DOI: 10.1371/journal.ppat.1008590] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Aldabbagh MA, Gitman MR, Kumar D, Humar A, Rotstein C, Husain S. The Role of Antiviral Prophylaxis for the Prevention of Epstein-Barr Virus-Associated Posttransplant Lymphoproliferative Disease in Solid Organ Transplant Recipients: A Systematic Review. Am J Transplant 2017;17:770-81. [DOI: 10.1111/ajt.14020] [Cited by in Crossref: 80] [Cited by in F6Publishing: 57] [Article Influence: 13.3] [Reference Citation Analysis]
5 Hernández DM, Valderrama S, Gualtero S, Hernández C, López M, Herrera MV, Solano J, Fiorentino S, Quijano S. Loss of T-Cell Multifunctionality and TCR-Vβ Repertoire Against Epstein-Barr Virus Is Associated With Worse Prognosis and Clinical Parameters in HIV+ Patients. Front Immunol 2018;9:2291. [PMID: 30337929 DOI: 10.3389/fimmu.2018.02291] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
6 Ressing ME, van Gent M, Gram AM, Hooykaas MJ, Piersma SJ, Wiertz EJ. Immune Evasion by Epstein-Barr Virus. Curr Top Microbiol Immunol 2015;391:355-81. [PMID: 26428381 DOI: 10.1007/978-3-319-22834-1_12] [Cited by in Crossref: 24] [Cited by in F6Publishing: 48] [Article Influence: 3.4] [Reference Citation Analysis]
7 Zur Hausen H, de Villiers EM. Reprint of: cancer "causation" by infections--individual contributions and synergistic networks. Semin Oncol 2015;42:207-22. [PMID: 25843727 DOI: 10.1053/j.seminoncol.2015.02.019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
8 Fujimoto A, Suzuki R. Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disorders after Hematopoietic Stem Cell Transplantation: Pathogenesis, Risk Factors and Clinical Outcomes. Cancers (Basel) 2020;12:E328. [PMID: 32024048 DOI: 10.3390/cancers12020328] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
9 Dalzini A, Petrara MR, Ballin G, Zanchetta M, Giaquinto C, De Rossi A. Biological Aging and Immune Senescence in Children with Perinatally Acquired HIV. J Immunol Res 2020;2020:8041616. [PMID: 32509884 DOI: 10.1155/2020/8041616] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
10 McLuckie AJ, Barrs VR, Wilson B, Westman ME, Beatty JA. Felis Catus Gammaherpesvirus 1 DNAemia in Whole Blood from Therapeutically Immunosuppressed or Retrovirus-Infected Cats. Vet Sci 2017;4:E16. [PMID: 29056675 DOI: 10.3390/vetsci4010016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
11 Pinzone MR, Berretta M, Cacopardo B, Nunnari G. Epstein-Barr Virus– and Kaposi Sarcoma-Associated Herpesvirus–Related Malignancies in the Setting of Human Immunodeficiency Virus Infection. Seminars in Oncology 2015;42:258-71. [DOI: 10.1053/j.seminoncol.2014.12.026] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 5.9] [Reference Citation Analysis]
12 Cai Q, Chen K, Young KH. Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorders. Exp Mol Med 2015;47:e133. [PMID: 25613730 DOI: 10.1038/emm.2014.105] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
13 Linke-Serinsöz E, Fend F, Quintanilla-Martinez L. Human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV) related lymphomas, pathology view point. Semin Diagn Pathol 2017;34:352-63. [PMID: 28506687 DOI: 10.1053/j.semdp.2017.04.003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
14 Ambrosio MR, Rocca BJ, Ginori A, Mourmouras V, Amato T, Vindigni C, Lazzi S, Leoncini L. A look into the evolution of Epstein-Barr virus-induced lymphoproliferative disorders: a case study. Am J Clin Pathol 2015;144:817-22. [PMID: 26486748 DOI: 10.1309/AJCP2G0VKTKPNPRR] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
15 Yoon S, Ryu KH, Baek HJ, An HJ, Joo YH. Epstein-Barr virus-positive diffuse large B-cell lymphoma with human immunodeficiency virus mimicking complicated frontal sinusitis: A case report. World J Clin Cases 2021; 9(7): 1654-1660 [PMID: 33728309 DOI: 10.12998/wjcc.v9.i7.1654] [Reference Citation Analysis]
16 Chiappini E, Bianconi M, Dalzini A, Petrara MR, Galli L, Giaquinto C, De Rossi A. Accelerated aging in perinatally HIV-infected children: clinical manifestations and pathogenetic mechanisms. Aging (Albany NY) 2018;10:3610-25. [PMID: 30418933 DOI: 10.18632/aging.101622] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
17 Pollock KM, Montamat-Sicotte DJ, Cooke GS, Kapembwa MS, Kon OM, Grass L, Sampson RD, Taylor GP, Lalvani A. Differences in antigen-specific CD4+ responses to opportunistic infections in HIV infection. Immun Inflamm Dis 2015;3:141-53. [PMID: 26417433 DOI: 10.1002/iid3.50] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
18 Petrara MR, Cattelan AM, Sasset L, Freguja R, Carmona F, Sanavia S, Zanchetta M, Del Bianco P, De Rossi A. Impact of monotherapy on HIV-1 reservoir, immune activation, and co-infection with Epstein-Barr virus. PLoS One 2017;12:e0185128. [PMID: 28926641 DOI: 10.1371/journal.pone.0185128] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
19 Pereira LMS, França EDS, Costa IB, Lima IT, Freire ABC, Ramos FLDP, Monteiro TAF, Macedo O, Sousa RCM, Freitas FB, Brasil Costa I, Vallinoto ACR. Epstein–Barr Virus (EBV) Genotypes Associated with the Immunopathological Profile of People Living with HIV-1: Immunological Aspects of Primary EBV Infection. Viruses 2022;14:168. [DOI: 10.3390/v14020168] [Reference Citation Analysis]
20 Hoshino A, Takashima T, Yoshida K, Morimoto A, Kawahara Y, Yeh TW, Okano T, Yamashita M, Mitsuiki N, Imai K, Sakatani T, Nakazawa A, Okuno Y, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Ogawa S, Kojima S, Morio T, Kanegane H. Dysregulation of Epstein-Barr Virus Infection in Hypomorphic ZAP70 Mutation. J Infect Dis 2018;218:825-34. [PMID: 29684201 DOI: 10.1093/infdis/jiy231] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
21 Xiao J, Du S, Tian Y, Su W, Yang D, Zhao H. Causes of Death Among Patients Infected with HIV at a Tertiary Care Hospital in China: An Observational Cohort Study. AIDS Res Hum Retroviruses 2016;32:782-90. [PMID: 26971827 DOI: 10.1089/AID.2015.0271] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
22 Petrara MR, Giunco S, Serraino D, Dolcetti R, De Rossi A. Post-transplant lymphoproliferative disorders: from epidemiology to pathogenesis-driven treatment. Cancer Lett. 2015;369:37-44. [PMID: 26279520 DOI: 10.1016/j.canlet.2015.08.007] [Cited by in Crossref: 80] [Cited by in F6Publishing: 68] [Article Influence: 11.4] [Reference Citation Analysis]
23 Tangye SG, Palendira U, Edwards ES. Human immunity against EBV-lessons from the clinic. J Exp Med 2017;214:269-83. [PMID: 28108590 DOI: 10.1084/jem.20161846] [Cited by in Crossref: 89] [Cited by in F6Publishing: 83] [Article Influence: 17.8] [Reference Citation Analysis]
24 Agrati C, Castilletti C, Casetti R, Sacchi A, Falasca L, Turchi F, Tumino N, Bordoni V, Cimini E, Viola D, Lalle E, Bordi L, Lanini S, Martini F, Nicastri E, Petrosillo N, Puro V, Piacentini M, Di Caro A, Kobinger GP, Zumla A, Ippolito G, Capobianchi MR. Longitudinal characterization of dysfunctional T cell-activation during human acute Ebola infection. Cell Death Dis 2016;7:e2164. [PMID: 27031961 DOI: 10.1038/cddis.2016.55] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 5.7] [Reference Citation Analysis]